|
Atomistry » Sodium » PDB 5hn3-5i9b » 5i8g | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Sodium » PDB 5hn3-5i9b » 5i8g » |
Sodium in PDB 5i8g: Cbp in Complex with CPD637 ((R)-4-Methyl-6-(1-Methyl-3-(1-Methyl-1H- Pyrazol-4-Yl)-1H-Indazol-5-Yl)-1,3,4,5-Tetrahydro-2H-Benzo[B][1, 4]Diazepin-2-One)Enzymatic activity of Cbp in Complex with CPD637 ((R)-4-Methyl-6-(1-Methyl-3-(1-Methyl-1H- Pyrazol-4-Yl)-1H-Indazol-5-Yl)-1,3,4,5-Tetrahydro-2H-Benzo[B][1, 4]Diazepin-2-One)
All present enzymatic activity of Cbp in Complex with CPD637 ((R)-4-Methyl-6-(1-Methyl-3-(1-Methyl-1H- Pyrazol-4-Yl)-1H-Indazol-5-Yl)-1,3,4,5-Tetrahydro-2H-Benzo[B][1, 4]Diazepin-2-One):
2.3.1.48; Protein crystallography data
The structure of Cbp in Complex with CPD637 ((R)-4-Methyl-6-(1-Methyl-3-(1-Methyl-1H- Pyrazol-4-Yl)-1H-Indazol-5-Yl)-1,3,4,5-Tetrahydro-2H-Benzo[B][1, 4]Diazepin-2-One), PDB code: 5i8g
was solved by
J.M.Murray,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 5i8g:
The structure of Cbp in Complex with CPD637 ((R)-4-Methyl-6-(1-Methyl-3-(1-Methyl-1H- Pyrazol-4-Yl)-1H-Indazol-5-Yl)-1,3,4,5-Tetrahydro-2H-Benzo[B][1, 4]Diazepin-2-One) also contains other interesting chemical elements:
Sodium Binding Sites:
The binding sites of Sodium atom in the Cbp in Complex with CPD637 ((R)-4-Methyl-6-(1-Methyl-3-(1-Methyl-1H- Pyrazol-4-Yl)-1H-Indazol-5-Yl)-1,3,4,5-Tetrahydro-2H-Benzo[B][1, 4]Diazepin-2-One)
(pdb code 5i8g). This binding sites where shown within
5.0 Angstroms radius around Sodium atom.
In total only one binding site of Sodium was determined in the Cbp in Complex with CPD637 ((R)-4-Methyl-6-(1-Methyl-3-(1-Methyl-1H- Pyrazol-4-Yl)-1H-Indazol-5-Yl)-1,3,4,5-Tetrahydro-2H-Benzo[B][1, 4]Diazepin-2-One), PDB code: 5i8g: Sodium binding site 1 out of 1 in 5i8gGo back to Sodium Binding Sites List in 5i8g
Sodium binding site 1 out
of 1 in the Cbp in Complex with CPD637 ((R)-4-Methyl-6-(1-Methyl-3-(1-Methyl-1H- Pyrazol-4-Yl)-1H-Indazol-5-Yl)-1,3,4,5-Tetrahydro-2H-Benzo[B][1, 4]Diazepin-2-One)
Mono view Stereo pair view
Reference:
A.M.Taylor,
A.Cote,
M.C.Hewitt,
R.Pastor,
Y.Leblanc,
C.G.Nasveschuk,
F.A.Romero,
T.D.Crawford,
N.Cantone,
H.Jayaram,
J.Setser,
J.Murray,
M.H.Beresini,
G.De Leon Boenig,
Z.Chen,
A.R.Conery,
R.T.Cummings,
L.A.Dakin,
E.M.Flynn,
O.W.Huang,
S.Kaufman,
P.J.Keller,
J.R.Kiefer,
T.Lai,
Y.Li,
J.Liao,
W.Liu,
H.Lu,
E.Pardo,
V.Tsui,
J.Wang,
Y.Wang,
Z.Xu,
F.Yan,
D.Yu,
L.Zawadzke,
X.Zhu,
X.Zhu,
R.J.Sims,
A.G.Cochran,
S.Bellon,
J.E.Audia,
S.Magnuson,
B.K.Albrecht.
Fragment-Based Discovery of A Selective and Cell-Active Benzodiazepinone Cbp/EP300 Bromodomain Inhibitor (Cpi-637). Acs Med.Chem.Lett. V. 7 531 2016.
Page generated: Mon Oct 7 21:33:16 2024
ISSN: ISSN 1948-5875 PubMed: 27190605 DOI: 10.1021/ACSMEDCHEMLETT.6B00075 |
Last articlesZn in 9JPJZn in 9JP7 Zn in 9JPK Zn in 9JPL Zn in 9GN6 Zn in 9GN7 Zn in 9GKU Zn in 9GKW Zn in 9GKX Zn in 9GL0 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |